Mannatech (NASDAQ:MTEX) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a research report sent to investors on Tuesday morning. The brokerage issued a buy rating on the stock.

Mannatech Stock Up 1.6 %

Mannatech stock opened at $8.33 on Tuesday. Mannatech has a fifty-two week low of $7.50 and a fifty-two week high of $15.10. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.51 and a current ratio of 1.07. The company has a market capitalization of $15.71 million, a P/E ratio of -6.94 and a beta of 1.20. The stock has a 50-day simple moving average of $8.65 and a 200-day simple moving average of $8.82.

Institutional Trading of Mannatech

A hedge fund recently raised its stake in Mannatech stock. Tower Research Capital LLC TRC raised its stake in shares of Mannatech, Incorporated (NASDAQ:MTEX) by 167.9% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,575 shares of the company’s stock after acquiring an additional 987 shares during the period. Tower Research Capital LLC TRC owned approximately 0.08% of Mannatech worth $27,000 as of its most recent SEC filing. Institutional investors and hedge funds own 12.98% of the company’s stock.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels.